Windtree Therapeutics (WINT) announced that it has signed a letter of intent to acquire CommLoan, a commercial tech finance company. CommLoan will retain key employees and become a subsidiary of Windtree. Windtree has provided bridge financing to CommLoan during this transition period. “Windtree is pleased to add a revenue generating fintech business as our subsidiary,” said Jed Latkin, Chief Executive Officer of Windtree. “We have spent several quarters trying to find the right business to spearhead our growth initiatives and we are very enthusiastic that CommLoan provides us with a unique advantage to seize on the growing trend in using software and AI to streamline the lending process. CommLoan has put together a massive proprietary database that would take years to replicate and creates a massive moat between them and the other companies trying to compete in this space.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WINT:
- Windtree Therapeutics Issues Convertible Notes for Acquisition
- Windtree may receive license agreement payments for renewed development work
- Windtree Therapeutics Delays Quarterly Report Filing
- Windtree Therapeutics announces patents allowed in Canada, Mexico
- Windtree Therapeutics to receive $7.5M in cash, securities
